Skip to main content
. 2017 Feb 7;12(2):e0170750. doi: 10.1371/journal.pone.0170750

Table 6. The overall survivals of different BCLC C HCC Prognostic (BCHP) stages in patients with advanced HCC treated with TACE.

Stage Total score N (%) OS* (months) P value
I 0–2 93 (39.1) 28.4 <0.001
II 3–5 135 (56.7) 11.8
III >5 10 (4.2) 2.4

OS*–Overall survival